Notwithstanding numerous setbacks, numerous MDM2 inhibitors have now progressed into late-stage medical progress. New procedures have also been developed to enhance the efficacy of MDM2 inhibitors and to mitigate their on-focus on toxicity. During this evaluate, we summarize the progress and challen